Projects per year
Search results
-
Active
Aanstelling UMD datacoördinator: Aanstelling UMD datacoördinator
van Karnebeek, C. (Principal investigator)
01/03/2025 → 01/09/2025
Project: Research
-
UMD Catalyst Grant: Effectiveness of nicotinamide riboside in Barth syndrome
van Karnebeek, C. (Principal investigator)
10/12/2024 → 31/12/2028
Project: Research
-
Silence Therap.: Reverse Cascade Screening for Elevated LP(a) in 4,000 Children: from Pedigrees to Cardiovascular Risk
Bosch, A. (Principal investigator) & Corpeleijn, W. (Project Leader)
15/11/2023 → 31/08/2025
Project: Research
-
FH-patiënt onderzoek: FH-patiënt onderzoek
Bosch, A. (Principal investigator), Corpeleijn, W. (Project Leader) & Wiegman, A. (Project Member)
Stichting Amsterdams Universiteitsfonds
01/09/2023 → 30/09/2025
Project: Research
-
SIMPATHIC: Accelerating drug repurposing for rare neurological, neurometabolic and neuromuscular disorders by exploiting SIMilarities in clinical and molecular PATHology
van Karnebeek, C. (Principal investigator)
01/07/2023 → 30/06/2028
Project: Research
-
RIVM 3-MCCD: 3-Methylcrotonyl-CoA carboxylase deficiëntie x, een aandoening waarop wordt gescreend in de neonatale hielprikscreening
Bosch, A. (Principal investigator)
RIVM: Rijksinstituut voor Volksgezondheid en Milieu
01/07/2023 → 30/06/2027
Project: Research
-
Recon4IMD: Reconstruction and Computational Modelling for Inherited Metabolic Diseases
van Karnebeek, C. (Principal investigator)
01/06/2023 → 31/05/2027
Project: Research
-
TCU Universitas: Transitional Care Unit: Jeroen Pit Huis: zorgevaluatie voor de uitrol naar alle regio’s in NL
van Karnebeek, C. (Principal investigator)
Stichting Steun Emma Kinderziekenhuis
01/01/2023 → 31/12/2027
Project: Research
-
NPC IntraBio: Effects of N-Acetyl-L-Leucine on Niemann-Pick disease type C (NPC): A Phase III, randomized, placebo-controlled, double-blind, crossover study
Bosch, A. (Principal investigator) & Brands, M. (Project Leader)
11/01/2022 → 31/05/2028
Project: Research
-
Transitional Care Unit: Bestendig (naar) Thuis: Transitional Care Unit: Bestendig (naar) Thuis
van Karnebeek, C. (Principal investigator)
01/05/2021 → 01/11/2026
Project: Research
-
Phenotips platform: Phenotips platform for the Solve the Unsolved study built by Gene42/PhenoTips
van Karnebeek, C. (Principal investigator)
01/02/2020 → 31/01/2026
Project: Research
-
MARS 110-504 Registry: Morquio A Registry Study (MARS)
Bosch, A. (Principal investigator) & Brands, M. (Project Leader)
BIOMARIN Int. Ltd, c/o ICON Clinical Research Ireland Ltd
16/06/2015 → 31/12/2025
Project: Research
-
Finished
Blue Daisy CTA: An Open-Label, Single-Arm, Multicenter Study of Intracerebral Administration of Adeno-Associated Viral Vectors Serotype rh10 Carrying the Human Nsulfoglucosamine sulfohydrolase (SGSH) cDNA for the ...
Bosch, A. (Principal investigator) & Brands, M. (Project Leader)
18/11/2024 → 31/12/2024
Project: Research
-
Voorzetting onderzoek Sanfilippo: Voorzetting onderzoek Sanfilippo
Bosch, A. (Principal investigator) & Wijburg, F. (Project Member)
01/02/2024 → 01/02/2025
Project: Research
-
PhD Scholarship 2024 M.Simon: New therapeutic approach for cystinosis based on in-depth study of cystine metabolism
van Karnebeek, C. (Principal investigator)
Stichting Steun Emma Kinderziekenhuis
01/10/2023 → 30/06/2025
Project: Research
-
PSA-PKU vervolg: PSA-PKU 2.0 project in relation to UMCG
Bosch, A. (Principal investigator)
01/01/2023 → 31/12/2023
Project: Research
-
Galactosemia: The search for new insights into the pathophysiology of galactosemia
Bosch, A. (Principal investigator)
01/01/2023 → 30/06/2024
Project: Research
-
Evinacumab in hoFH children: CTCA Results in Homozygous Familial Hypercholesterolemia Upon Intensive LDL-C Lowering Treatment with Evinacumab
Bosch, A. (Principal investigator) & Corpeleijn, W. (Project Leader)
Ultragenyx Pharmaceutical, Inc.
21/06/2022 → 12/12/2023
Project: Research
-
EMDR: EMDR en preconceptie screening
Wijburg, F. (Project Leader)
01/01/2022 → 31/12/2023
Project: Research
-
Cannabidiol (CDB olie): Cannabidiol (CBD olie) voor de behandeling van gedragsproblemen bij patiënten met Sanfilippo
Wijburg, F. (Project Leader)
01/01/2022 → 31/12/2023
Project: Research
-
Lp(a) Levels in 4,000 Children referred to a Pedia: Lp(a) Levels in 4,000 Children referred to a Pediatric Lipid Clinic: Association with Atherosclerosis
Wiegman, A. (Principal investigator)
15/11/2021 → 14/02/2023
Project: Research
-
Akcea - IST Peds: Akcea - IST Peds
van Karnebeek, C. (Principal investigator)
21/10/2021 → 30/06/2025
Project: Research
-
Elucidating Classical Galactosemie: the search for: Elucidating Classical Galactosemie: the search for modifier genes
Bosch, A. (Principal investigator)
Stichting Steun Emma Kinderziekenhuis
01/09/2021 → 01/07/2023
Project: Research
-
Programma coördinator UMD: Programma coördinator UMD
van Karnebeek, C. (Principal investigator)
01/05/2021 → 31/12/2024
Project: Research
-
EJPRD Charlie: CHAnging Rare disorders of LysInE metabolism - CHARLIE
van Karnebeek, C. (Principal investigator)
01/05/2021 → 30/04/2025
Project: Research
-
PKU: Determination of the suitability of protein substitutes for management of PKU to be introduced in the Netherlands
Bosch, A. (Principal investigator)
01/03/2021 → 01/09/2022
Project: Research
-
Living with Galactosemia: Living with Galactosemia
Bosch, A. (Principal investigator)
01/01/2021 → 14/11/2022
Project: Research
-
GRIN2B: L-serine - Effectiveness of Lserine supplementation in children with GRIN2B deficiency: nof1 series
van Karnebeek, C. (Principal investigator)
01/11/2020 → 31/10/2024
Project: Research
-
N-of-1 for all: Scoping Literature Review of treatments, effects, evidence for Inborn errors of Metabolism and Tranlation of this review into data for IEMbase.
van Karnebeek, C. (Principal investigator) & Brands, M. (Project Leader)
01/11/2020 → 31/10/2024
Project: Research
-
Biomarkers voor klassieke galactosemie: Biomarkers voor klassieke galactosemie
Bosch, A. (Principal investigator)
Stichting Steun Emma Kinderziekenhuis
01/07/2020 → 31/12/2021
Project: Research
-
SOBI003-001: An open, non-controlled, parallel, ascending multiple-dose, multicenter study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of SOBI003 in pediatric MPS IIIA patients
Wijburg, F. (Project Leader)
Swedish Orphan Biovitrum BVBA/SPRL
01/01/2020 → 01/01/2021
Project: Research
-
PDE KLIK: Pyridoxine-dependent epilepsy (PDE-ALDH7A1) in adulthood: delineation of disease course & treatment effects
van Karnebeek, C. (Principal investigator)
01/12/2019 → 31/12/2024
Project: Research
-
UMD 2019-2023: United for Metabolic Diseases
van Karnebeek, C. (Principal investigator)
01/05/2019 → 31/08/2023
Project: Research
-
FON TCU: Fonds Op Naam Transitie Care Unit .
van Karnebeek, C. (Principal investigator)
Stichting Steun Emma Kinderziekenhuis
01/01/2019 → 30/04/2021
Project: Research
-
Dieet App: Nederlandse App Suite ter ondersteuning van het metabool dieet voor erfelijke stofwisselingsziekten
van Karnebeek, C. (Principal investigator)
01/02/2018 → 31/12/2024
Project: Research